vaccine trials

Moderna said Monday that it is “actively discussing a proposal with the FDA” to expand its coronavirus vaccine trial to include children ages 5 to 11. The company hopes to expand its trial to include children in this age group by the end of the year.

9-year-old Daemo Gregorie-Cradick is one of the 250 kids ages 5 to 11 who are participating in a trial of the Pfizer coronavirus vaccine at the Children’s Hospital Colorado. If the trial is successful, experts say vaccines for kids under 12 could be just months away.

15-year-old Audrey Baker and her brother both took part in a clinical trial at Cincinnati Children’s Hospital Medical Center for Pfizer’s COVID-19 vaccine. Baker is urging children and parents to get their shots and help the nation out of this pandemic.

As COVID-19 vaccine trials begin for children, many parents may be understandably wary about signing their own child up as a subject. So we got Peter Pitts, a former FDA associate commissioner and president of the Center for Medicine in the Public Interest, to break down how vaccine trials for children work and how researchers ensure they’re safe.

Dances and duets are not the only videos trending on TikTok. NBC News youth and internet culture reporter Kalhan Rosenblatt discusses how young people are turning to the video app for information about the COVID-19 vaccines, and gives us a firsthand look at a TikToker’s experience as a vaccine trial participant.

The Connecticut Chapter of the American Academy of Pediatrics said ideally, it would like to see the COVID-19 vaccine available to kids by the next school year, with details about exactly when it will become available and how it will be administered still in the works. “I have a 20-month-old toddler at home and I’m eight months pregnant with...

Dr. Albert Ko said it’s the hospitalizations, a key metric used to determine the pandemic’s path, that’s most concerning.

Moderna and Pfizer have now both reported that their COVID-19 vaccines have been highly effective in trials. But how do they work, and what are the differences between the two? Benjamin Neuman, a professor of biological studies at Texas A&M, breaks down the specifics of both vaccines.

Moderna announced Monday that preliminary data from its phase 3 trial showed its coronavirus vaccine is more than 94% effective in preventing COVID-19. Dr. Bob Lahita, a clinical professor at New York Medical College and the Chairman of the Department of Medicine at St. Joseph’s Healthcare System, breaks down the “very exciting news,” and why March and April could be...

Pfizer has released early data that shows its COVID-19 vaccine is more than 90% effective. Former FDA Associate Commissioner Peter Pitts says this effectiveness rate represents a “game changer” but cautions there is still a long road ahead before a vaccine is ready for the general public.

Pfizer’s Phase 3 trial of a COVID-19 vaccine showed it was 90% effective.

Dr. Chris Pernell, a New Jersey public health physician, became a patient in Moderna’s COVID-19 vaccine trial after she lost her father to the virus. She joins LX News to discuss why it was important for her to join the trial to honor her father and to advocate for better health care for Black and brown communities that have suffered...

A California woman volunteering for Moderna’s COVID-19 vaccine trial said she wasn’t afraid to offer herself up as a test subject, and never had second thoughts even after the side effects kicked in. Debbie Honeycutt, 69, said she started feeling mild, flu-like symptoms after her second dose of the vaccine. The Scripps Ranch resident got her first dose of...

Writer Molly Jong-Fast walks us through her experience of participating in a COVID-19 vaccine trial, why she did it, and why you are much safer taking the vaccine than taking your chances of contracting the virus.

The president of Xavier University of Louisiana, Reynold Verret, is participating in a Covid-19 vaccine trial and encouraging Black students to follow suit. He explains why it is so important for people of color to be represented in the vaccine trials given that they are disproportionately dying from the virus.